KFDA to get tough over postmarketing surveillance system

Published: 2009-04-02 07:00:00

Updated: 2009-04-02 07:00:00

The Korea Food and Drug Administration will embark on looking into the postmarketing surveillance (PMS) system of the pharmaceutical industry as the PMS system has been utilized as a tool of promoting new products.

PMS is the practice of monitoring a pharmaceutical drug after it has been relea...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK